What is the OVID stock price prediction for next 2 weeks?

According to our price prediction algorithm,Ovid Therapeutics Inc. (OVID) price will be around $1.50 in the next 2 weeks. This means it will decrease by -6.175 from the last closing price. This prediction may vary from other time period filters for OVID stock.

What can be the highest Possible price of OVID stock in next 2 weeks?

Our forecast algorithm expects that in 2 weeks, OVID can achieve the highest price of $1.62 which is 1.1333923082843256 higher than last closing price. This prediction may vary from other time period filters for OVID stock.

What can be the lowest Possible price of OVID stock in next 2 weeks?

As per the forecast and algorithmic analysis, OVID stock price can be as low as $1.37 which is -14.544415950465462 lower than the current price in the next 2 weeks. This prediction may vary from other time period filters for OVID stock.

Will OVID stock go high in the next 2 weeks?

No, our stock forecasting algorithm shows that OVID stock will lose-6.175 in the next 2 weeks. This prediction may vary from other time period filters for OVID stock.

What is OVID stock last closing price?

Last closing price of OVID stock was $1.60.

What is OVID stock price prediction?

OVID stock price prediction means predicting the future closing prices of OVID stock based on its past data. Our forecasting algorithm uses various machine learning and deep learning techniques to forecast the future behavior of OVID stock in a certain time period.

How we predict OVID stock future prices?

If you are searching for OVID stock forecast, analysis or price prediction, then you might be wondering what Ovid Therapeutics Inc. (OVID) will do in the future. Our OVID price predictions are based on various Machine Learning based algorithms with an aim to try and predict future price movements. This OVID price prediction will likely answer most of your questions.

How frequent we update OVID stock predictions?

We are updating the forecasts for the OVID stock on daily basis.

Is using ML forecasting for OVID stock a good way?

Yes. Stock Price Prediction is one of the most exciting applications of Machine Learning. By leveraging data from the past, it is possible to use forecasting models to make accurate predictions about future stock prices. This can be incredibly beneficial for investors and traders, as it gives them the ability to make more informed decisions about when to buy and sell. Investing in the stock market can be a risky endeavor, but leveraging Machine Learning can make it a bit less daunting and more profitable.

Is the Prediction for OVID stock same for all the time periods?

No, the prediction for OVID stock is not same for all time periods. The forecasts may vary depending on the differences in the time period.

Ovid Therapeutics Inc. Stock Forecast and Stock Price Prediction

Stock Forecast Chart

Stock Price Prediction Summary

Closed Price$1.60-5.33%Since 2 Weeks

Predicted Price$1.50-6.18%For 2 Weeks

Upper Predicted Price$1.621.13%For 2 Weeks

Lower Predicted Price$1.37-14.54%For 2 Weeks

Forecast Score Based on 2 Weeks

Based on our forecast, the price of OVID will decline by -6.18% over the next 2 Weeks and hit $1.50 by Friday, February 20, 2026. In that time frame, OVID's share price is expected to range between $1.37 and $1.62.

BearishAverageBullish

Date	Predicted Lower	Predicted	Predicted Upper
Feb 20, 2026	1.37	1.50	1.62
Feb 19, 2026	1.38	1.50	1.63
Feb 18, 2026	1.36	1.48	1.60
Feb 17, 2026	1.39	1.51	1.64
Feb 16, 2026	1.40	1.52	1.65
Feb 13, 2026	1.39	1.51	1.65
Feb 12, 2026	1.38	1.51	1.64
Feb 11, 2026	1.36	1.49	1.62
Feb 10, 2026	1.40	1.53	1.66
Feb 9, 2026	1.40	1.53	1.65

OVID shares rose +10.34% in Friday, February 6, 2026's trading session, rising from a previous close of $1.45 to move at $1.60. The stock demonstrated notable intraday movement (see OVID's key stats for a full breakdown), fluctuating between $1.45 and $1.61, a +11.03% trading range. While recent weeks have seen some volatility, OVID has managed to secure a -8.05% drop over the past 2 weeks. The upward price movement was accompanied by increased trading volume, with approximately 1.58M shares changing hands, 93.3K more than the previous session. This amounted to $2.52M in total market activity.

Will OVID Continue Its Upward Trend?

According to analyst ratings and projections for OVID, Ovid Therapeutics Inc. shares are anticipated to increase by +1.12%, potentially reaching $1.62 per share by February 20, 2026. Short-term technical indicators currently suggest a neutral sentiment for OVID. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 11 positive trading days within the past 30 sessions. Based on the OVID stock forecast, now is a good time to buy OVID stock because its current trading price is +6.58% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on OVID covering social and institutional perspectives.

OVID Technical Momentum: Overbought, Oversold, or Neutral?

An analysis of Relative Strength Index (RSI) indicators provides insight into OVID's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 49.97% to 51.13%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 52.13%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 52.81%, maintains a neutral outlook for the long term. Insights into OVID's shareholder base show how institutional investors are positioning themselves during these momentum shifts

Ovid Therapeutics Short-Term Forecasts

OVID Forecast For Next 5 Days

Our algorithm anticipates Ovid Therapeutics (OVID) stock could hit $1.44 by Feb 13, 2026. This represents a -9.89% fall from today's price, following a -5.59% change over the past five days.

OVID Forecast For Next 30 Days

Based on analysis of market trends, the outlook for Ovid Therapeutics Inc. (OVID) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $1.44, which would mean a -10.00% decrease from the current price of $1.60. Projections for this period range from a high of $1.74 to a low of $1.09.

OVID Forecast For Next 90 Days

Our proprietary market analysis suggests predictions for Ovid Therapeutics's price over the next three months point to a rise. OVID stock is expected to peak at $15.25 on May 06, 2026 after potentially dipping to $8.37 on Feb 12, 2026. On average, OVID is likely to trade around $10.07 in the coming 90 days.

Ovid Therapeutics Stock Forecast 2025

Based on our predictive models, Ovid Therapeutics (OVID) is expected to trade between $8.37 and $36.82 throughout 2026. This would result in an average price of $17.99, potentially offering investors a +1,024.37% return from current levels.

Ovid Therapeutics Inc. Monthly Forecast 2026–2027

February 2026

According to our latest forecast models, Ovid Therapeutics Inc. (OVID) is positioned to show a strong performance in February 2026. The price is predicted to move between $8.37 and $9.28, settling at an average of $8.72. This could translate to a +445.00% gain.

March 2026

Based on current market signals, Ovid Therapeutics Inc. is projected to trend march 2026. We forecast a trading range from $9.25 to $10.71, with a likely average price of $10.04. Investors could expect a potential return of +527.50%.

April 2026

Our predictive algorithms indicate Ovid Therapeutics Inc. stock may see a shift in April 2026. The expected range spans $9.02–$13.27, with an average target of $10.23. This represents a positive outlook and a possible gain of +539.38%.

May 2026

Analyzing established trends, Ovid Therapeutics Inc. looks set to move in May 2026. Projections place the stock between $13.26 and $19.35, averaging around $16.14. This suggests a +908.75% gain from current levels.

June 2026

Market indicators suggest Ovid Therapeutics Inc. could experience notable changes during June 2026. Prices could fluctuate within $11.68 to $20.13, with a midpoint forecast of $16.02. The stock might deliver a +901.25% gain.

July 2026

Forecasting for July 2026, models estimate that Ovid Therapeutics Inc. may undergo key fluctuations. If trends hold, the stock might trade between $11.59 and $21.21, averaging $14.56. This signals a positive trajectory with potential returns around +810.00%.

August 2026

According to our latest forecast models, Ovid Therapeutics Inc. (OVID) is positioned to show a strong performance in August 2026. The price is predicted to move between $18.35 and $28.55, settling at an average of $22.13. This could translate to a +1,283.12% gain.

September 2026

Based on current market signals, Ovid Therapeutics Inc. is projected to trend september 2026. We forecast a trading range from $21.08 to $33.88, with a likely average price of $23.14. Investors could expect a potential return of +1,346.25%.

October 2026

Our predictive algorithms indicate Ovid Therapeutics Inc. stock may see a shift in October 2026. The expected range spans $27.54–$36.82, with an average target of $29.27. This represents a positive outlook and a possible gain of +1,729.38%.

November 2026

Analyzing established trends, Ovid Therapeutics Inc. looks set to move in November 2026. Projections place the stock between $20.43 and $35.64, averaging around $23.97. This suggests a +1,398.12% gain from current levels.

December 2026

Market indicators suggest Ovid Therapeutics Inc. could experience notable changes during December 2026. Prices could fluctuate within $19.98 to $28.97, with a midpoint forecast of $21.13. The stock might deliver a +1,220.62% gain.

January 2027

Forecasting for January 2027, models estimate that Ovid Therapeutics Inc. may undergo key fluctuations. If trends hold, the stock might trade between $20.66 and $29.65, averaging $22.14. This signals a positive trajectory with potential returns around +1,283.75%.

February 2027

According to our latest forecast models, Ovid Therapeutics Inc. (OVID) is positioned to show a strong performance in February 2027. The price is predicted to move between $19.58 and $25.00, settling at an average of $19.26. This could translate to a +1,103.75% gain.

OVID's history of dividends and stock splits also plays a role in long-term investor confidence.